Browse All

Current Filters

CLEAR FILTER x

TITLE

Neutropenia and Neutropenic Fever in Patients with Multiple Sclerosis on B-cell Depleting Therapies

Author:Doerfler, Matthew   Alvarez, Enrique   Wolf, Andrew   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.004  

Author Institution:University of Colorado, Aurora, CO  

Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension

Author:Oh, Jiwon   Drulovic, Jelena   Dufek, Michal   Budincevic, Hrvoje   Habek, Mario   Caunt, Maresa   Sierzega, Malgorzata   Clayton, David   Chen, Ying-Fang   Ratchford, Jack   Goodyear, Alexandra   Bar-Or, Amit   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.005  

Author Institution:St. Anne's University Hospital Brno, Teplice, Czech Republic  Solmed Polyclinic and Sveti Duh University Hospital, Zagreb, Croatia  University Hospital Center Zagreb, Zagreb, Croatia  Genentech, Inc., South San Francisco, CA  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Pennsylvania, Philadelphia, PA  

Enhanced Safety Profile of Ocrelizumab Over Rituximab in Multiple Sclerosis Treatment

Author:Cerono, Gabriel   Cree, Bruce   Hauser, Stephen   Baranzini, Sergio   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.006  

Author Institution:UCSF, San Francisco, CA  UCSF, Multiple Sclerosis Center, San Francisco, CA  UCSF Weill Institute for Neurosciences, San Francisco, CA  

Comprehensive Review of Hypogammaglobulinemia and Infection Rates in MS Patients Treated with Anti-CD20 Antibodies

Author:Elgenidy, Anas   Alomari, Omar   Al-kurdi, Mohammed Al-mahdi   Mohamed, Lobna A.   M. Ghoneim, Mohamed   Fathy, Ahmed Wagdy   Hassaan, Hazem Khaled   Anan, Ahmed   Nader Abdelhalim, Nagham   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.007  

Author Institution:Hamidiye International School of Medicine, University of Health Sciences, Istanbul, Turkey , Istanbul, Turkey  

Comparison of B-cell Depletion and Natalizumab for Treatment of Multiple Sclerosis: A Semi-supervised Causal Analysis

Author:DiSanto, Dominic   Tang, Weijing   Zhu, Wen   Cai, Tianxi   Xia, Zongqi   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.008  

Author Institution: